(EPD) Enterprise Products Partners - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US2937921078
Stock: Natural Gas, Liquids, Crude Oil, Petrochemicals
Total Rating 52
Risk 57
Buy Signal 0.09
| Risk 5d forecast | |
|---|---|
| Volatility | 17.2% |
| Relative Tail Risk | 0.19% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.84 |
| Alpha | 8.32 |
| Character TTM | |
|---|---|
| Beta | 0.383 |
| Beta Downside | 1.014 |
| Drawdowns 3y | |
|---|---|
| Max DD | 15.40% |
| CAGR/Max DD | 1.37 |
EPS (Earnings per Share)
Revenue
Description: EPD Enterprise Products Partners March 04, 2026
Enterprise Products Partners LP (EPD) is a midstream energy company. This sector focuses on transporting and processing energy commodities, acting as a crucial link between production and consumption.
EPD operates across four segments: NGL Pipelines & Services, Crude Oil Pipelines & Services, Natural Gas Pipelines & Services, and Petrochemical & Refined Products Services. Midstream companies often generate revenue through stable, fee-based contracts for their infrastructure.
The NGL Pipelines & Services segment includes natural gas processing, NGL pipelines, fractionation, storage, and marine terminals. The Crude Oil Pipelines & Services segment manages crude oil pipelines, storage, marine terminals, and marketing, utilizing a fleet of tank trucks.
The Natural Gas Pipelines & Services segment focuses on gathering, treating, and transporting natural gas, including the operation of underground salt dome storage facilities. The Petrochemical & Refined Products Services segment operates propylene fractionation, butane isomerization, and octane enhancement facilities, alongside refined products pipelines, terminals, and marketing.
For a deeper dive into EPDs financial performance and market position, consider exploring its profile on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 5.80b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -2.32 > 1.0 |
| NWC/Revenue: 1.00% < 20% (prev -0.08%; Δ 1.08% < -1%) |
| CFO/TA 0.11 > 3% & CFO 8.53b > Net Income 5.80b |
| Net Debt (656.0m) to EBITDA (9.92b): 0.07 < 3 |
| Current Ratio: 1.04 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.19b) vs 12m ago -0.23% < -2% |
| Gross Margin: 13.62% > 18% (prev 0.13%; Δ 1350 % > 0.5%) |
| Asset Turnover: 67.84% > 50% (prev 72.85%; Δ -5.02% > 0%) |
| Interest Coverage Ratio: 5.21 > 6 (EBITDA TTM 9.92b / Interest Expense TTM 1.40b) |
Altman Z''
| A: 0.01 (Total Current Assets 13.36b - Total Current Liabilities 12.83b) / Total Assets 77.90b |
| B: error (Retained Earnings missing) |
| C: 0.09 (EBIT TTM 7.30b / Avg Total Assets 77.53b) |
| D: 1.26 (Book Value of Equity 59.91b / Total Liabilities 47.41b) |
Beneish M
| DSRI: 0.75 (Receivables 6.50b/9.24b, Revenue 52.60b/56.22b) |
| GMI: 0.94 (GM 13.62% / 12.85%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 0.94 (Revenue 52.60b / 56.22b) |
| TATA: -0.04 (NI 5.80b - CFO 8.53b) / TA 77.90b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of EPD shares?
As of March 05, 2026, the stock is trading at USD 37.17 with a total of 4,228,127 shares traded.
Over the past week, the price has changed by +3.48%, over one month by +5.60%, over three months by +15.85% and over the past year by +19.48%.
Over the past week, the price has changed by +3.48%, over one month by +5.60%, over three months by +15.85% and over the past year by +19.48%.
Is EPD a buy, sell or hold?
Enterprise Products Partners has received a consensus analysts rating of 4.16.
Therefore, it is recommended to buy EPD.
- StrongBuy: 9
- Buy: 4
- Hold: 6
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the EPD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 36.8 | -1% |
| Analysts Target Price | 36.8 | -1% |
EPD Fundamental Data Overview March 05, 2026
P/E Trailing = 14.0526
P/E Forward = 13.245
P/S = 1.5388
P/B = 2.7322
P/EG = 2.1288
Revenue TTM = 52.60b USD
EBIT TTM = 7.30b USD
EBITDA TTM = 9.92b USD
Long Term Debt = 31.11b USD (from longTermDebt, two quarters ago)
Short Term Debt = 1.62b USD (from shortTermDebt, last quarter)
Debt = 1.62b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 656.0m USD (from netDebt column, last quarter)
Enterprise Value = 81.59b USD (80.94b + Debt 1.62b - CCE 969.0m)
Interest Coverage Ratio = 5.21 (Ebit TTM 7.30b / Interest Expense TTM 1.40b)
EV/FCF = 45.48x (Enterprise Value 81.59b / FCF TTM 1.79b)
FCF Yield = 2.20% (FCF TTM 1.79b / Enterprise Value 81.59b)
FCF Margin = 3.41% (FCF TTM 1.79b / Revenue TTM 52.60b)
Net Margin = 11.03% (Net Income TTM 5.80b / Revenue TTM 52.60b)
Gross Margin = 13.62% ((Revenue TTM 52.60b - Cost of Revenue TTM 45.43b) / Revenue TTM)
Gross Margin QoQ = 14.51% (prev 13.78%)
Tobins Q-Ratio = 1.05 (Enterprise Value 81.59b / Total Assets 77.90b)
Interest Expense / Debt = 23.08% (Interest Expense 375.0m / Debt 1.62b)
Taxrate = 0.24% (4.00m / 1.66b)
NOPAT = 7.28b (EBIT 7.30b * (1 - 0.24%))
Current Ratio = 1.04 (Total Current Assets 13.36b / Total Current Liabilities 12.83b)
Debt / Equity = 0.05 (Debt 1.62b / totalStockholderEquity, last quarter 30.10b)
Debt / EBITDA = 0.07 (Net Debt 656.0m / EBITDA 9.92b)
Debt / FCF = 0.37 (Net Debt 656.0m / FCF TTM 1.79b)
Total Stockholder Equity = 29.32b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.48% (Net Income 5.80b / Total Assets 77.90b)
RoE = 19.78% (Net Income TTM 5.80b / Total Stockholder Equity 29.32b)
RoCE = 12.08% (EBIT 7.30b / Capital Employed (Equity 29.32b + L.T.Debt 31.11b))
RoIC = 11.81% (NOPAT 7.28b / Invested Capital 61.69b)
WACC = 7.64% (E(80.94b)/V(82.56b) * Re(7.33%) + D(1.62b)/V(82.56b) * Rd(23.08%) * (1-Tc(0.00)))
Discount Rate = 7.33% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.16%
[DCF] Terminal Value 77.26% ; FCFF base≈2.50b ; Y1≈2.17b ; Y5≈1.72b
[DCF] Fair Price = 15.21 (EV 33.55b - Net Debt 656.0m = Equity 32.90b / Shares 2.16b; r=7.64% [WACC]; 5y FCF grow -16.29% → 2.90% )
EPS Correlation: 53.20 | EPS CAGR: 6.75% | SUE: 1.54 | # QB: 1
Revenue Correlation: -15.50 | Revenue CAGR: 1.57% | SUE: 0.40 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.66 | Chg7d=-0.022 | Chg30d=-0.022 | Revisions Net=-1 | Analysts=2
EPS current Year (2026-12-31): EPS=2.76 | Chg7d=-0.087 | Chg30d=-0.102 | Revisions Net=-4 | Growth EPS=+3.1% | Growth Revenue=+0.2%
EPS next Year (2027-12-31): EPS=3.06 | Chg7d=+0.061 | Chg30d=+0.041 | Revisions Net=-1 | Growth EPS=+10.8% | Growth Revenue=+6.7%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.8% (Discount Rate 7.9% - Earnings Yield 7.1%)
[Growth] Growth Spread = +9.9% (Analyst 10.8% - Implied 0.8%)
P/E Forward = 13.245
P/S = 1.5388
P/B = 2.7322
P/EG = 2.1288
Revenue TTM = 52.60b USD
EBIT TTM = 7.30b USD
EBITDA TTM = 9.92b USD
Long Term Debt = 31.11b USD (from longTermDebt, two quarters ago)
Short Term Debt = 1.62b USD (from shortTermDebt, last quarter)
Debt = 1.62b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 656.0m USD (from netDebt column, last quarter)
Enterprise Value = 81.59b USD (80.94b + Debt 1.62b - CCE 969.0m)
Interest Coverage Ratio = 5.21 (Ebit TTM 7.30b / Interest Expense TTM 1.40b)
EV/FCF = 45.48x (Enterprise Value 81.59b / FCF TTM 1.79b)
FCF Yield = 2.20% (FCF TTM 1.79b / Enterprise Value 81.59b)
FCF Margin = 3.41% (FCF TTM 1.79b / Revenue TTM 52.60b)
Net Margin = 11.03% (Net Income TTM 5.80b / Revenue TTM 52.60b)
Gross Margin = 13.62% ((Revenue TTM 52.60b - Cost of Revenue TTM 45.43b) / Revenue TTM)
Gross Margin QoQ = 14.51% (prev 13.78%)
Tobins Q-Ratio = 1.05 (Enterprise Value 81.59b / Total Assets 77.90b)
Interest Expense / Debt = 23.08% (Interest Expense 375.0m / Debt 1.62b)
Taxrate = 0.24% (4.00m / 1.66b)
NOPAT = 7.28b (EBIT 7.30b * (1 - 0.24%))
Current Ratio = 1.04 (Total Current Assets 13.36b / Total Current Liabilities 12.83b)
Debt / Equity = 0.05 (Debt 1.62b / totalStockholderEquity, last quarter 30.10b)
Debt / EBITDA = 0.07 (Net Debt 656.0m / EBITDA 9.92b)
Debt / FCF = 0.37 (Net Debt 656.0m / FCF TTM 1.79b)
Total Stockholder Equity = 29.32b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.48% (Net Income 5.80b / Total Assets 77.90b)
RoE = 19.78% (Net Income TTM 5.80b / Total Stockholder Equity 29.32b)
RoCE = 12.08% (EBIT 7.30b / Capital Employed (Equity 29.32b + L.T.Debt 31.11b))
RoIC = 11.81% (NOPAT 7.28b / Invested Capital 61.69b)
WACC = 7.64% (E(80.94b)/V(82.56b) * Re(7.33%) + D(1.62b)/V(82.56b) * Rd(23.08%) * (1-Tc(0.00)))
Discount Rate = 7.33% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.16%
[DCF] Terminal Value 77.26% ; FCFF base≈2.50b ; Y1≈2.17b ; Y5≈1.72b
[DCF] Fair Price = 15.21 (EV 33.55b - Net Debt 656.0m = Equity 32.90b / Shares 2.16b; r=7.64% [WACC]; 5y FCF grow -16.29% → 2.90% )
EPS Correlation: 53.20 | EPS CAGR: 6.75% | SUE: 1.54 | # QB: 1
Revenue Correlation: -15.50 | Revenue CAGR: 1.57% | SUE: 0.40 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.66 | Chg7d=-0.022 | Chg30d=-0.022 | Revisions Net=-1 | Analysts=2
EPS current Year (2026-12-31): EPS=2.76 | Chg7d=-0.087 | Chg30d=-0.102 | Revisions Net=-4 | Growth EPS=+3.1% | Growth Revenue=+0.2%
EPS next Year (2027-12-31): EPS=3.06 | Chg7d=+0.061 | Chg30d=+0.041 | Revisions Net=-1 | Growth EPS=+10.8% | Growth Revenue=+6.7%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.8% (Discount Rate 7.9% - Earnings Yield 7.1%)
[Growth] Growth Spread = +9.9% (Analyst 10.8% - Implied 0.8%)